Your browser doesn't support javascript.
loading
Glucocerebrosidase deficits in sporadic Parkinson disease.
Murphy, Karen E; Halliday, Glenda M.
Affiliation
  • Murphy KE; Neuroscience Research Australia; School of Medical Sciences; Faculty of Medicine; University of New South Wales; Sydney, Australia.
  • Halliday GM; Neuroscience Research Australia; School of Medical Sciences; Faculty of Medicine; University of New South Wales; Sydney, Australia.
Autophagy ; 10(7): 1350-1, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24915553
Parkinson disease (PD) is a progressive neurodegenerative movement disorder characterized pathologically by abnormal SNCA/α-synuclein protein inclusions in neurons. Impaired lysosomal autophagic degradation of cellular proteins is implicated in PD pathogenesis and progression. Heterozygous GBA mutations, encoding lysosomal GBA/glucocerebrosidase (glucosidase, ß, acid), are the greatest genetic risk factor for PD, and reduced GBA and SNCA accumulation are related in PD models. Here we review our recent human brain tissue study demonstrating that GBA deficits in sporadic PD are related to the early accumulation of SNCA, and dysregulation of chaperone-mediated autophagy (CMA) pathways and lipid metabolism.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Glucosylceramidase Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Autophagy Year: 2014 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Glucosylceramidase Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Autophagy Year: 2014 Document type: Article Affiliation country: Country of publication: